Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Common Equity (2017 - 2025)

Historic Common Equity for Cirtran (CIRX) over the last 14 years, with Q3 2025 value amounting to -$25.5 million.

  • Cirtran's Common Equity fell 826.86% to -$25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.5 million, marking a year-over-year decrease of 826.86%. This contributed to the annual value of -$24.4 million for FY2024, which is 1206.17% down from last year.
  • Latest data reveals that Cirtran reported Common Equity of -$25.5 million as of Q3 2025, which was down 826.86% from -$25.1 million recorded in Q2 2025.
  • Cirtran's 5-year Common Equity high stood at -$21.8 million for Q4 2023, and its period low was -$43.0 million during Q3 2023.
  • Its 5-year average for Common Equity is -$34.1 million, with a median of -$40.9 million in 2022.
  • In the last 5 years, Cirtran's Common Equity soared by 4822.86% in 2023 and then crashed by 1206.17% in 2024.
  • Cirtran's Common Equity (Quarter) stood at -$40.6 million in 2021, then decreased by 3.7% to -$42.1 million in 2022, then surged by 48.23% to -$21.8 million in 2023, then decreased by 12.06% to -$24.4 million in 2024, then fell by 4.66% to -$25.5 million in 2025.
  • Its Common Equity was -$25.5 million in Q3 2025, compared to -$25.1 million in Q2 2025 and -$24.6 million in Q1 2025.